Cleveland BioLabs
CBLI
#9801
Rank
HK$0.38 B
Marketcap
HK$24.67
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -HK$21.36 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are HK$0.63 Million. In 2020 the company made an earning of -HK$19.99 Million a decrease over its 2019 earnings that were of -HK$18.38 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-HK$21.36 Million6.85%
2020-HK$19.99 Million8.8%
2019-HK$18.38 Million-50.81%
2018-HK$37.36 Million-14.3%
2017-HK$43.59 Million-11.88%
2016-HK$49.46 Million-50.9%
2015-HK$0.11 Billion-10.24%
2014-HK$0.12 Billion-37.5%
2013-HK$0.18 Billion-23.2%
2012-HK$0.24 Billion19.68%
2011-HK$0.2 Billion133.81%
2010-HK$83.56 Million68.22%
2009-HK$49.68 Million-55.51%
2008-HK$0.12 Billion-45.62%
2007-HK$0.21 Billion255.63%
2006-HK$57.73 Million198.18%
2005-HK$19.36 Million-1.25%
2004-HK$19.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.15 B-299,603.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.76 B-596,599.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
HK$62.51 B-291,937.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.81 B-330,710.78%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$72.54 B-338,799.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$96.26 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.11 B-817,651.66%๐Ÿ‡บ๐Ÿ‡ธ USA